Literature DB >> 21321490

Copper supplementation improves functional activities of daily living in adults with copper deficiency.

Calin I Prodan1, Meheroz Rabadi, Andrea S Vincent, Linda D Cowan.   

Abstract

OBJECTIVE: Neurologic manifestations of copper deficiency in adults are increasingly recognized. We sought to determine if copper supplementation over a period of 12 months would improve functional activities of daily living (ADLs) in patients with copper deficiency.
METHODS: We studied 15 consecutively diagnosed patients with copper deficiency that received 12 months of copper supplementation. Functional ADLs were evaluated by the Barthel Index (BI), administered at the time of diagnosis and repeated after 12 months of copper supplementation.
RESULTS: BI scores were significantly higher after 12 months of continued supplementation when compared with initial scores [(mean ± SD), 74 ± 11.7 versus 83 ± 13.2, P = 0.007, paired t-test]. A significant inverse linear correlation between the duration of symptoms before treatment and the change in the BI scores was noted (P = 0.005).
CONCLUSIONS: Early initiation and sustained supplementation with copper for at least 12 months may improve functional ADLs in patients with copper deficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321490     DOI: 10.1097/CND.0b013e3181dc34c0

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  4 in total

Review 1.  Copper.

Authors:  James F Collins; Leslie M Klevay
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

2.  Copper deficiency as a cause of neutropenia in a case of coeliac disease.

Authors:  Daisy Khera; Baldev Sharma; Kuldeep Singh
Journal:  BMJ Case Rep       Date:  2016-09-15

3.  Therapies for ataxias.

Authors:  Laurence Martineau; Anne Noreau; Nicolas Dupré
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

4.  Ocular lesions from copper deficiency.

Authors:  Leslie M Klevay
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.